Schering Takes Aim At Glenmark Over Zetia
In the latest legal feud over a blockbuster cholesterol drug, Schering-Plough Corp. has hauled Glenmark Pharmaceuticals to court on allegations that the Indian generics maker has infringed a patent covering its...To view the full article, register now.
Already a subscriber? Click here to view full article